JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB5745

Rabbit Anti-Armenian hamster IgG H&L (HRP)

3

(1 Review)

|

(14 Publications)

Suitable for Dot, EM, IHC-P, WB, ELISA, ICC. Ideal for western blot. Cited in 14 publications.
4 Images
Western blot - Rabbit Anti-Armenian hamster IgG H&L (HRP) (AB5745)
  • WB

Lab

Western blot - Rabbit Anti-Armenian hamster IgG H&L (HRP) (AB5745)

The expression profile/ molecular weight observed is consistent with what has been described in the literature (PMID : 11384980).

Lysates should be made freshly and used in WB immediately.

Blocking/Dilution buffer : 5% NFDM/TBST.

Exposure times : Lanes 1/2:3 seconds; Lane 3:15 seconds; Lane 4:37 seconds.

This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab243248).

All lanes:

Western blot - Anti-p115-RhoGEF antibody [JH-1] (<a href='/en-us/products/primary-antibodies/p115-rhogef-antibody-jh-1-ab243248'>ab243248</a>) at 1/1000 dilution

Lane 1:

A20 (mouse reticulum sarcoma B lymphocyte), whole cell lysate at 10 µg

Lane 2:

EL4 (mouse lymphoma T lymphocyte), whole cell lysate at 10 µg

Lane 3:

PC-12 (rat adrenal gland pheochromocytoma), whole cell lysate at 10 µg

Lane 4:

C6 (rat glial tumor glial cell), whole cell lysate at 10 µg

Secondary

All lanes:

Western blot - Rabbit Anti-Armenian hamster IgG H&L (HRP) (ab5745) at 1/5000 dilution

Predicted band size: 102 kDa

Observed band size: 115 kDa

false

Western blot - Rabbit Anti-Armenian hamster IgG H&L (HRP) (AB5745)
  • WB

Supplier Data

Western blot - Rabbit Anti-Armenian hamster IgG H&L (HRP) (AB5745)

Blocking/diluting buffer and concentration : 5% NFDM/TBST. Upregulating the expression of TPN protein by IFN gamma treatment (PMID : 11169257). Exposure time : 3.25 seconds.

All lanes:

Western blot - Anti-TPN antibody [5D3] (<a href='/en-us/products/primary-antibodies/tpn-antibody-5d3-ab307298'>ab307298</a>) at 1/1000 dilution

Lane 1:

Untreated B16-F10 (Mouse skin melanoma), whole cell lysate 20 μg

Lane 2:

B16-F10 treated with /ml IFN gamma for 16 hours, whole cell lysate 20 μg

Observed band size: 48 kDa

false

Exposure time: 3.25s

Dot Blot - Rabbit Anti-Armenian hamster IgG H&L (HRP) (AB5745)
  • Dot

Supplier Data

Dot Blot - Rabbit Anti-Armenian hamster IgG H&L (HRP) (AB5745)

Dot blot analysis of CD30 using ab324907 at 1 : 1000 (0.998 ug/ml) followed by a Rabbit Anti-Armenian hamster IgG H&L (HRP) (ab5745) at 1 : 2000 dilution.

Lane1 : Recombinant Mouse CD30/TNFRSF8 Fc Chimera Protein

Exposure time : 10 seconds.

Blocking and diluting buffer and concentration : 5% NFDM/TBST.

All lanes:

Dot Blot - Anti-CD30 antibody [mCD30.1] (<a href='/en-us/products/primary-antibodies/cd30-antibody-mcd301-ab324907'>ab324907</a>) at 1/1000 dilution

All lanes:

Recombinant Mouse CD30/TNFRSF8 Fc Chimera Protein

Secondary

All lanes:

Dot Blot - Rabbit Anti-Armenian hamster IgG H&L (HRP) (ab5745) at 1/2000 dilution

false

Exposure time: 10s

ELISA - Rabbit Anti-Armenian hamster IgG H&L (HRP) (AB5745)
  • ELISA

Supplier Data

ELISA - Rabbit Anti-Armenian hamster IgG H&L (HRP) (AB5745)

ab5745 tested against purified Armenian Hamster IgG. Each well was coated in duplicate with 1.0 μg of Armenian Hamster IgG. The starting dilution of antibody was 5μg/ml and the X-axis represents the log10 of a 3-fold dilution. This titration is a 4-parameter curve fit where the IC50 is defined as the titer of the antibody. Assay performed using 3% fish gelatin as blocking buffer and TMB substrate

Key facts

Host species

Rabbit

Target species

Armenian hamster

Target isotype

IgG

Target specificity

Heavy & Light chains

Minimal cross-reactivity
Pre-adsorbed

No

Conjugation

HRP

Excitation/Emission
Applications

IHC-P, WB, ELISA, Dot, EM, ICC

applications

Clonality

Polyclonal

Isotype

IgG

Specificity

Greatly diminished reactivity will occur against Golden Syrian Hamster IgG.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Reactivity", "Dilution Info", "Notes"] }, "values": { "Dot": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" }, "EM": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" }, "IHC-P": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"1/1000 - 1/5000", "notes":"<p></p>" }, "WB": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"1/1000 - 1/5000", "notes":"<p></p>" }, "ELISA": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"1/150000 - 1/250000", "notes":"<p>This product has been assayed against 1.0 ug of Armenian Hamster IgG in a standard capture ELISA using ABTS (2,2’-azino-bis-[3-ethylbenthiazoline-6-sulfonic acid]) as a substrate for 30 minutes at room temperature.</p>" }, "ICC": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"1/1000 - 1/5000", "notes":"<p></p>" } } }

Properties and storage information

Form
Liquid
Purification technique
Affinity purification
Purification notes
This product was prepared from monospecific antiserum by immunoaffinity chromatography using Armenian Hamster IgG coupled to agarose.
Storage buffer
Preservative: 0.01% Gentamicin sulphate Constituents: 1% BSA, 0.88% Sodium chloride, 0.424% Potassium phosphate solution
Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
+4°C

Product protocols

Publications (14)

Recent publications for all applications. Explore the full list and refine your search

Frontiers in immunology 15:1445294 PubMed39281671

2024

The influence of 4G/5G polymorphism in the plasminogen-activator-inhibitor-1 promoter on COVID-19 severity and endothelial dysfunction.

Applications

Unspecified application

Species

Unspecified reactive species

Tetiana Yatsenko,Ricardo Rios,Tatiane Nogueira,Yousef Salama,Satoshi Takahashi,Eisuke Adachi,Yoko Tabe,Nobutaka Hattori,Taro Osada,Toshio Naito,Kazuhisa Takahashi,Koichi Hattori,Beate Heissig

Frontiers in immunology 14:1299792 PubMed38313435

2024

Urokinase-type plasminogen activator and plasminogen activator inhibitor-1 complex as a serum biomarker for COVID-19.

Applications

Unspecified application

Species

Unspecified reactive species

Tetiana Yatsenko,Ricardo Rios,Tatiane Nogueira,Satoshi Takahashi,Yoko Tabe,Toshio Naito,Kazuhisa Takahashi,Koichi Hattori,Beate Heissig

Nature communications 14:8048 PubMed38052854

2023

Leukemia-intrinsic determinants of CAR-T response revealed by iterative in vivo genome-wide CRISPR screening.

Applications

Unspecified application

Species

Unspecified reactive species

Azucena Ramos,Catherine E Koch,Yunpeng Liu-Lupo,Riley D Hellinger,Taeyoon Kyung,Keene L Abbott,Julia Fröse,Daniel Goulet,Khloe S Gordon,Keith P Eidell,Paul Leclerc,Charles A Whittaker,Rebecca C Larson,Audrey J Muscato,Kathleen B Yates,Juan Dubrot,John G Doench,Aviv Regev,Matthew G Vander Heiden,Marcela V Maus,Robert T Manguso,Michael E Birnbaum,Michael T Hemann

Oncogene 41:3511-3523 PubMed35688945

2022

Addiction of Merkel cell carcinoma to MUC1-C identifies a potential new target for treatment.

Applications

Unspecified application

Species

Unspecified reactive species

Yoshihiro Morimoto,Atsushi Fushimi,Nami Yamashita,Masayuki Hagiwara,Atrayee Bhattacharya,Jingwei Cheng,Thomas C Frost,Rehan Ahmad,Tatsuaki Daimon,Lei Huang,Tsuyoshi Hata,Hidekazu Takahashi,Masaaki Yamamoto,Yozo Suzuki,James A DeCaprio,Donald Kufe

Molecular cancer research : MCR 20:1379-1390 PubMed35612556

2022

Dependence on the MUC1-C Oncoprotein in Classic, Variant, and Non-neuroendocrine Small Cell Lung Cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Atsushi Fushimi,Yoshihiro Morimoto,Satoshi Ishikawa,Nami Yamashita,Atrayee Bhattacharya,Tatsuaki Daimon,Hasan Rajabi,Caining Jin,Masayuki Hagiwara,Yota Yasumizu,Zhou Luan,Wenhao Suo,Kwok-Kin Wong,Henry Withers,Song Liu,Mark D Long,Donald Kufe

Biomaterials 231:119675 PubMed31838346

2019

Post-production modifications of murine mesenchymal stem cell (mMSC) derived extracellular vesicles (EVs) and impact on their cellular interaction.

Applications

Unspecified application

Species

Unspecified reactive species

Sarah Le Saux,Hanna Aarrass,Joséphine Lai-Kee-Him,Patrick Bron,Jean Armengaud,Guylaine Miotello,Justine Bertrand-Michel,Emeric Dubois,Simon George,Orestis Faklaris,Jean-Marie Devoisselle,Philippe Legrand,Joël Chopineau,Marie Morille

Frontiers in pharmacology 10:290 PubMed30971927

2019

Evodiamine Augments NLRP3 Inflammasome Activation and Anti-bacterial Responses Through Inducing α-Tubulin Acetylation.

Applications

Unspecified application

Species

Unspecified reactive species

Chen-Guang Li,Qiong-Zhen Zeng,Ming-Ye Chen,Li-Hui Xu,Cheng-Cheng Zhang,Feng-Yi Mai,Chen-Ying Zeng,Xian-Hui He,Dong-Yun Ouyang

Bone 117:23-30 PubMed30217615

2018

Collagen type I degradation fragments act through the collagen receptor LAIR-1 to provide a negative feedback for osteoclast formation.

Applications

Unspecified application

Species

Unspecified reactive species

Iris Boraschi-Diaz,John S Mort,Dieter Brömme,Yotis A Senis,Alexandra Mazharian,Svetlana V Komarova

Oncoimmunology 6:e1338998 PubMed28932637

2017

MUC1-C promotes the suppressive immune microenvironment in non-small cell lung cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Audrey Bouillez,Dennis Adeegbe,Caining Jin,Xiufeng Hu,Ashujit Tagde,Maroof Alam,Hasan Rajabi,Kwok-Kin Wong,Donald Kufe

Oncogene 36:4037-4046 PubMed28288138

2017

MUC1-C integrates PD-L1 induction with repression of immune effectors in non-small-cell lung cancer.

Applications

Unspecified application

Species

Unspecified reactive species

A Bouillez,H Rajabi,C Jin,M Samur,A Tagde,M Alam,M Hiraki,T Maeda,X Hu,D Adeegbe,S Kharbanda,K-K Wong,D Kufe
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com